LEUKOPENIA

Clinical trials for LEUKOPENIA explained in plain language.

Never miss a new study

Get alerted when new LEUKOPENIA trials appear

Sign up with your email to follow new studies for LEUKOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 3

Can a single drug boost blood counts and delay cancer in High-Risk patients?

Disease control Recruiting now

This study tests the drug luspatercept in 50 adults with clonal cytopenias of uncertain significance (CCUS), a condition where low blood cell counts increase the risk of developing blood cancers like leukemia. Participants receive injections every three weeks for up to 48 weeks. …

Matched conditions: LEUKOPENIA

Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

LEUKOPENIA

Get alerted when new LEUKOPENIA trials appear

Can a single drug boost blood counts and delay cancer in High-Risk patients?